Potential Benefits of Phytochemicals for Abdominal Aortic Aneurysm.


Journal

Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157

Informations de publication

Date de publication:
2021
Historique:
received: 30 10 2020
revised: 28 03 2021
accepted: 02 04 2021
pubmed: 16 6 2021
medline: 7 1 2022
entrez: 15 6 2021
Statut: ppublish

Résumé

Abdominal aortic aneurysms (AAAs) are a leading cause of death in older adults due to aortic rupture. There are currently no effective medical therapies for AAA, with surgery being the only acceptable treatment. There is frequently an extended period between AAA diagnosis and treatment by corrective surgery, during which an effective drug therapy could prevent or delay the need for AAA repair. This review aimed to critically summarize prior research investigating the potential benefits of phytochemicals in preventing or treating AAA. In vitro, in vivo, and human studies examining the effect of phytochemicals in AAA models and patients were critically summarised. Some preliminary data support the further investigation of curcumin, radix astragali, grape seed polyphenols, resveratrol, Ginkgo biloba extract (EGb 761), Ginsenoide Rb1, Dan Hong, Epigallocatechin-3-gallate, Baicalein, Fucoidan, Quercetin, and Salvianolic acid as potential treatments for AAA. Experimental in vivo and in vitro studies suggest the potential benefits of a number of medicinal herbs and phytochemicals in preventing or reducing the progression of AAA. In order to assess whether these findings can be translated into proven treatments, adequately designed double-blind randomized clinical trials will be required.

Sections du résumé

BACKGROUND BACKGROUND
Abdominal aortic aneurysms (AAAs) are a leading cause of death in older adults due to aortic rupture. There are currently no effective medical therapies for AAA, with surgery being the only acceptable treatment. There is frequently an extended period between AAA diagnosis and treatment by corrective surgery, during which an effective drug therapy could prevent or delay the need for AAA repair.
OBJECTIVE OBJECTIVE
This review aimed to critically summarize prior research investigating the potential benefits of phytochemicals in preventing or treating AAA.
METHODS METHODS
In vitro, in vivo, and human studies examining the effect of phytochemicals in AAA models and patients were critically summarised.
RESULTS RESULTS
Some preliminary data support the further investigation of curcumin, radix astragali, grape seed polyphenols, resveratrol, Ginkgo biloba extract (EGb 761), Ginsenoide Rb1, Dan Hong, Epigallocatechin-3-gallate, Baicalein, Fucoidan, Quercetin, and Salvianolic acid as potential treatments for AAA.
CONCLUSION CONCLUSIONS
Experimental in vivo and in vitro studies suggest the potential benefits of a number of medicinal herbs and phytochemicals in preventing or reducing the progression of AAA. In order to assess whether these findings can be translated into proven treatments, adequately designed double-blind randomized clinical trials will be required.

Identifiants

pubmed: 34126879
pii: CMC-EPUB-116135
doi: 10.2174/0929867328666210614113116
doi:

Substances chimiques

Phytochemicals 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8595-8607

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Azar Hosseini (A)

Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.

Peter E Penson (PE)

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.

Arrigo F G Cicero (AFG)

Atherosclerosis Research Unit, Medical and Surgical Sciences Department, Sant'Orsola-- Malpighi Hospital, University of Bologna, Bologna, Italy.

Jonathan Golledge (J)

Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University, Townsville, Queensland, Australia | Department of Vascular and Endovascular Surgery, Townsville, University Hospital, Townsville, Queensland, Australia.

Khalid Al-Rasadi (K)

Department of Clinical Biochemistry, Sultan Qaboos University Hospital, Muscat, Oman.

Tannaz Jamialahmadi (T)

Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran | Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Amirhossein Sahebkar (A)

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran | Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran | School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH